Access Only Access1 Access2 Access3 November 3, 2022 A Summary of Pharmacotherapies for Smoking Cessation
Access Only Access1 Access2 Access3 October 26, 2022 Evidence for Smoking Cessation after Cardiovascular Events – Part 1
Access Only Access1 Access2 Access3 October 20, 2022 Gadopiclenol (Eluciremâ„¢) for Contrast-Enhanced MRI
Access Only Access1 Access2 Access3 October 12, 2022 New Opioid Receptor Agonist Approved for Pruritus in Chronic Kidney Disease: Difelikefalin (Korsuva)
Access1 Access2 Access3 Medical Investigations Medication & Drugs October 6, 2022 Omlonti (Omidenepag Isopropyl) for the Reduction of Elevated Intraocular Pressure
Access Only Access1 Access2 Access3 September 12, 2022 Risdiplam: Spinal Muscular Atrophy (SMA) Treatment
Access Only Access1 Access2 Access3 September 3, 2022 HSA approves Belimumab (Benlysta) for Lupus Nephritis
Access Only Access1 Access2 Access3 August 25, 2022 Pralsetinib: Targeted Therapies for RET-Fusion Positive NSCLC
Access1 Access2 Access3 Medication & Drugs August 11, 2022 Thalidomide (Old Drug for New Indication: Multiple Myeloma)
Access1 Access2 Access3 Cancer Medication & Drugs Respiratory July 27, 2022 Tepotinib (Tepmetko) for METex14-altered NSCLC